Robert Cook-Deegan, MD, is a professor in the School for the Future of Innovation in Society, and with the Consortium for Science, Policy & Outcomes at Arizona State University. He founded and directed Duke’s Center for Genome Ethics, Law & Policy 2002–2012, and taught in Duke’s in-Washington program through June 2016. Before Duke he worked at the National Academies of Science, Engineering and Medicine; National Center for Human Genome Research (NIH); and congressional Office of Technology Assessment. He obtained his MD from the University of Colorado in 1979; and a BA in chemistry from Harvard in 1975. He is the author of The Gene Wars: Science, Politics, and the Human Genome and over 300 other publications.
Jacqueline J. Glover, Ph.D., is a Professor in the Department of Pediatrics and at the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus where she directs efforts in clinical ethics consultation. She is the co-medical director of the Ethics Consultation Service at the University of Colorado Hospital and an ethics consult faculty lead at the Children’s Hospital Colorado. Her research interests include pediatric ethics, ethics consultation, rural bioethics, interprofessional education, professionalism, and health policy.
Christine Grady, RN, Ph.D., is a nurse-bioethicist and a senior investigator who currently serves as the Chief of the Department of Bioethics at the National Institutes of Health Clinical Center. Her research is primarily in the ethics of clinical research, including informed consent, vulnerability, study design, recruitment, and international research ethics, as well as ethical issues faced by nurses and other health care providers. She is an elected fellow of the Hastings Center and of the American Academy of Nursing, a senior research fellow at the Kennedy Institute of Ethics and an elected member of the National Academy of Medicine. She holds a B.S. in nursing and biology from Georgetown University, a M.S.N. in community health nursing from Boston College, and a Ph.D. in philosophy from Georgetown University.
Eric T. Juengst, Ph.D., is Director of the Center for Bioethics and Professor in the Departments of Social Medicine and Genetics at the UNC-Chapel Hill School of Medicine. He did his masters and doctoral work at Georgetown between 1978–1984 and since 1997 he has been the principal investigator of a series of NIH-funded research projects examining the ethical, conceptual, and social policy issues that will be raised by the availability of genetic and genomic technologies.
Steven J. McCormack, Ph.D., is a serial entrepreneur, executive and investor in the biotechnology and medical device field. He was previously a Senior Fellow at the Kennedy Institute of Ethics and a post-doctoral fellow at the Lombardi Cancer Center, both at Georgetown University. McCormack received his Ph.D. from the Interdepartmental Biomolecular Science and Engineering program from University of California, Santa Barbara. He obtained a bachelor’s degree in biology from the College of the Holy Cross in Worcester, MA.
Eric M. Meslin Ph.D., FCAHS, is President and CEO of the Council of Canadian Academies (CCA) a not-for-profit organization that conducts independent, evidence-based assessments of leading policy topics for the Government of Canada. Trained in bioethics at the Kennedy Institute of Ethics, he has held academic appointments at Indiana University, University of Toronto, University of Western Australia, and Université de Toulouse, as well positions at the National Human Genome Research Institute and the US National Bioethics Advisory Commission.
Carol Mason Spicer, Ph.D., is a Senior Program Officer in the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine. Prior to joining the Academies, she served as editor of the Kennedy Institute of Ethics Journal at Georgetown University.